Comparative toxicity of alloxan, N-alkylalloxans and ninhydrin to isolated pancreatic islets in vitro

Journal of Endocrinology

Volumn 155, Issue 2, 1997, Pages 283-293

  Jorns A ^a   Munday, R ^b   Tiedge, M ^a   Lenzen, S ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b RUAKURA RESEARCH CENTRE   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

3 METHYLGLUCOSE; ALLOXAN; GLUCOSE; N BUTYLALLOXAN; N ISOBUTYLALLOXAN; N METHYLALLOXAN; NINHYDRIN; PYRIMIDINE DERIVATIVE; UNCLASSIFIED DRUG;

ALLOXAN DIABETES MELLITUS; ANIMAL TISSUE; ARTICLE; CELL DEATH; CELL PROTECTION; CONTROLLED STUDY; CYTOTOXICITY; DIABETOGENESIS; FEMALE; IN VITRO STUDY; MALE; MOUSE; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL;

ALLOXAN; ANIMALS; CELL DEATH; INDICATORS AND REAGENTS; ISLETS OF LANGERHANS; MICE; MICROSCOPY, ELECTRON; NECROSIS; NINHYDRIN;

EID: 1842373814     PISSN: 00220795     EISSN: None     Source Type: Journal    
DOI: 10.1677/joe.0.1550283     Document Type: Article

References (50)

1. Abdel-Rahman MS, Elrakhawy FI & Iskander FA 1992 Protection of B cells against the effect of alloxan. Toxicology Letters 63 155-164.
2. Bernhard K, Favarger M, Renold A & Spühler O 1947 Beiträge zur Alloxan-Glucosurie. Helvetica Chimica Acta 30 1666-1672.
3. Biltz H 1912 Alloxan-anhydrid und seine Methylderivate. Berichte der Deutschen Chemischen Gesellschaft 45 3659-3675.
4. Biltz H & Damm P 1913 Über die Gewinnung von Dialursäuren und Uramilen. Berichte der Deutschen Chemischen Gesellschaft 46 3662-3673.
5. Boquist L 1977 The endocrine pancreas in early alloxan diabetes. Including study of the alloxan inhibitory effect of feeding and some hexoses. Acta Pathologica et Microbiologica Scandinavica A 85 219-229.
6. Bouqist L & Lorentzon R 1979 Stereological study of endoplasmic reticulum. Golgi complex and secretory granules in the beta cells of normal and alloxan-treated mice. Virchows Archive (B) 31 235-241.
7. Boquist L, Nelson L & Lorentzon R 1983 Uptake of labeled alloxan in mouse organs and mitochondria in vivo and in vitro. Endocrinology 113 943-948.
8. Breton JC, Schmitt H & Neuzil E 1957 Toxicité aiguë de la ninhydrine (hydrate d'indanetrione) pour la souris blanche. Comptes Rendues de la Societe de Biologic (Paris) 151 719-722.
9. Brückmann G & Wertheimer E 1945 Hiabetogenic action of alloxan derivatives. Nature 155 267-268.
10. Brückmann G & Wertheimer E 1947 Alloxan studies: The action of alloxan homologues and related compounds. Journal of Biological Chemistry 168 241-256.
11. Brückmann G & Isaacs SD 1949 Preparation and properties of new derivatives of alloxan. Journal of the American Clhemical Society 71 390-392.
12. Carter WJ & Younathan ES 1962 Studies on protection against the diabetogenic effect of alloxan by glucose. Proceedings of the Society for Experimental Biology and Medicine 109 611-612.
13. Cooperstein SJ & Watkins D 1978 Effect of sulfhydryl-binding reagents on islet tissue permeability: protection and reversal by D-glucose and phlorizin. Journal of Pharmacologyand Experimental Therapeutics 204 230-239.
14. Cooperstein SJ & Watkins D 1981 Action of toxic drugs on islet cells. In The Islet of Langerhans. pp 387-425. Eds SJ Cooperstein & D Watkins. New York: Academic Press.
15. Eizirik OE & Sandler S 1988 Functional restoration of cultured mouse pancreatic islets after in vitro exposure to alloxan. Pharmacology and Toxicology 63 396-399.
16. Gorus FK, Malaisse WJ & Pipeleers DG 1982 Selective uptake of alloxan by pancreatic beta cells. Biochemical Journal 208 513-515.
17. Hammarström E, Hellman B & Ullberg S 1966 On the accumulation of alloxan in the pancreatic beta cells. Diabetologia 3 340-345.
18. Hansen BH & Dryhurst G 1971 Electrochemistry of alloxan and its N-methyl derivatives in aqueous solution. Journal of the Electrochemical Society 118 1747-1752.
19. Hellman B & Hellerström C 1954 Size differences of the B-cell nuclei in the islet tissue of normal and alloxan-treated rats. Acta Pathologica et Microbiologica Scandinavica 45 113-122.
20. Hidy PH 1946 Structural requirements for diabetogenic action in alloxan and related compounds. Journal of Biological Chemistry 163 307-311.
21. Jennische E & Hansson HA 1986 Relation between alloxan-iduced plasma membrane dysfunction and inhibition of insulin secretion in pancreatic beta cells in vivo. Acta Pathologica Microbiologica et Immunologica Scandinavica A 94 153-158.
22. Jörns A 1994 Immunocytochemical and ultrastructural heterogeneities of normal and glibenclamide stimulated pancreatic beta cells in the rat. Virchows Archiv 425 305-313.
23. Jörns A & Grube D 1991 The endocrine pancreas of glucagon- and somatostatin-immunized rabbits. II. Electron microscopy. Cell and Tisue Research 265 261-273.
24. Kass EH & Waisbren BA 1945 A method for consistent induction of chronic hyperglycemia with alloxan. Proceedings of the Society for Experimental Biology and Medicine 60 303-306.
25. Lacy PE & Cardeza AF 1958 Electron microscopy of early effects of alloxan on the pancreas of the rat. Federation Proceedings 17 444.
26. Lenzen S 1979 Insulin secretion by isolated perfused rat and mouse pancreas. American Journal of Physiology 236 E391-E400.
27. Lenzen S & Panten U 1988 Alloxan: history and mechanism of action. Diabetologia 31 337-342.
28. Lenzen S & Munday R 1991 Thiol-group reactivity, hydrophilicity, and stability of alloxan, its reduction products and its N-methyl derivatives and a comparison with ninhydrin. Biochemical Pharmacology 42 1385-1391.
29. Lernmark Å 1974 The preparation of, and studies on free cell suspensions from mouse pancreatic islets. Diabetologica 10 431-438.
30. Lorentzon R & Boquist L 1979 Stereological study of beta cell mitochondria in alloxan-treated mice. Virchows Archiv (B) 31 227-233.
31. Malaisse WJ 1982 Alloxan toxicity to the pancreatic beta cell: a new hypothesis. Biochemical Pharmacology 31 3527-3534.
32. Malaisse-Lagae F, Sener A & Malaisse WJ 1983 Contrasting modes of action of D-glucose and 3-O-methyl-D-glucose as protectors of the rat pancreatic beta cell against alloxan. Biochimica et Biophysica Acta 762 36-43.
33. Melmed RN, Benitez CJ & Holt SJ 1973 Intermediate cells of the pancreas. 3. Selective autophagy and destruction of beta-granules in intermediate cells of the rat pancreas induced by alloxan and streptozotocin. Journal of Cell Science 13 297-315.
34. Munday R, 1988 Dialuric acid autoxidation: effects of transition metals on the reaction rate and on the generation of 'active oxygen' species. Biochemical Pharmacology 37 4119-413.
35. Munday R, Ludwig K & Lenzen S 1993 The relationship between physicochemical properties and the biological effects of alloxan and several N-alkyl substituted alloxan derivatives. Journal of Endocrinology 139 153-163.
36. Norlund R, Grankvist K, Norlund L Täljedal IB 1984 Ultrastructure and membrane permeability of cultured pancreatic beta cells exposed to alloxan or hydroxydopamine. Virchows Archiv (A) 404 31-38.
37. Oberley LW 1988 Free radicals and diabetes. Free Radical Biology and Medicine 5 113-124.
38. Orci L, Amherdt M, Malaisse-Lagae F, Ravazzola M, Malaisse WJ, Perrelet A & Renold AE 1976 Islet cell membrane alteration by diabetogenic drugs. Laboratory Investigaton 34 451-454.
39. Rossini AA, Arcangeli MA & Cahill GJ 1975 Studies of alloxan toxicity on the beta cell. Diabetes 24 516-522.
40. Said A, Fleita DH & Shinouda HG 1977 Reactions of alloxan and related compounds. Zeitschrift fü Naturforschumg 32b 447-452.
41. Sandler S & Swenne I 1983 Streptozotocin, but not alloxan, induces DNA repair synthesis in mouse pancreatic islets in vitro. Diabetologica 25 444-447.
42. Seheynius A & Täljedal IB 1971 On the mechanism of glucose protection against alloxan toxicity. Diabetologia 7 252-255.
43. Tomita T & Watanabe I 1976 The effect of alloxan on the permeability of isolated pancreatic islets to horseradish peroxidase. Virchows Archiv (B) 22 217-232.
44. Watkins D, Cooperstein SJ & Lazarow A 1964 Effect of alloxan on permeability of pancreatic islet tissue in vitro. American Journal of Physiology 207 436-440.
45. Weaver DC, McDaniel ML & Lacy PE 1978 Alloxan uptake by isolated rat islets ot Langerhans. Endocrinology 102 1847-1855.
46. Weaver DC, Barry CD, McDaniel ML, Marshall GR & Lacy PE 1979 Molecular requirements for recognition at a glucoreceptor for insulin release. Molecular Pharmacology 16 361-368.
47. Webb JL 1966 Alloxan. In Enzyme and Metabolic Inhibitors, pp 367-419. Ed JL Webb, New York: Academic Press.
48. Wellmann KF, Volk BW & Lazarus SS 1967 Ultrastructural pancreatic beta-cell changes in rabbits after small and large doses of alloxan. Diabetes 16 242-251.
49. Winterbourn CC & Munday R 1989 Glutathione redox cycling of alloxan. Mechanisms of superoxide dismutase inhibition and of metal-catalysed OH formation. Biochemical Pharmacology 38 271-277.
50. Zawalich WS & Beidler LM 1973 Glucose and alloxan interactions in the pancreatic islets. American Journal of Physiology 224 963-966.